{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:19:33Z","timestamp":1774408773634,"version":"3.50.1"},"reference-count":32,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8407","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T12:01:48Z","timestamp":1515499308000},"source":"Crossref","is-referenced-by-count":15,"title":["MicroRNA\u2011146a\/NAPDH oxidase4 decreases reactive oxygen species generation and inflammation in a diabetic nephropathy model"],"prefix":"10.3892","author":[{"given":"Rong Jun","family":"Wan","sequence":"first","affiliation":[{"name":"Department of Urology, Hospital of Tianjin Nankai, Nankai, Tianjin 300100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue Hong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital of Tianjin Nankai, Nankai, Tianjin 300100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"key20200713224432_b1-mmr-17-03-4759","first-page":"161","article-title":"Efficacy of long-term low-dose sulodexide in diabetic and non-diabetic nephropathies","volume":"53","author":"Zili\u015fteanu","year":"2015","journal-title":"Rom J Intern Med"},{"key":"key20200713224432_b2-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1272\/jnms.82.84","article-title":"Beraprost sodium protects against diabetic nephropathy in patients with arteriosclerosis obliterans: A prospective, randomized, open-label study","volume":"82","author":"Shima","year":"2015","journal-title":"J Nippon Med Sch"},{"key":"key20200713224432_b3-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2215\/CJN.07460713","article-title":"Potassium handling with dual renin-angiotensin system inhibition in diabetic nephropathy","volume":"9","author":"Van Buren","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20200713224432_b4-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.gene.2015.05.073","article-title":"Promoter hypermethylation of let-7a-3 is relevant to its down-expression in diabetic nephropathy by targeting UHRF1","volume":"570","author":"Peng","year":"2015","journal-title":"Gene"},{"key":"key20200713224432_b5-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2013.06.009","article-title":"MicroRNAs: Potential mediators and biomarkers of diabetic complications","volume":"64","author":"Kato","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"key20200713224432_b6-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"811","DOI":"10.5301\/jn.5000262","article-title":"The pathogenesis of diabetic nephropathy: Focus on microRNAs and proteomics","volume":"26","author":"Conserva","year":"2013","journal-title":"J Nephrol"},{"key":"key20200713224432_b7-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00125-012-2768-x","article-title":"Towards microRNA-based therapeutics for diabetic nephropathy","volume":"56","author":"Alvarez","year":"2013","journal-title":"Diabetologia"},{"key":"key20200713224432_b8-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/ijms17040518","article-title":"MicroRNAs in hyperglycemia induced endothelial cell dysfunction","volume":"17","author":"Silambarasan","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20200713224432_b9-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ejphar.2011.10.041","article-title":"Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: A comparison with n-acetylcysteine","volume":"674","author":"Ahmad","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"key20200713224432_b10-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.fct.2011.11.028","article-title":"Schizandrin prevents damage of murine mesangial cells via blocking NADPH oxidase-induced ROS signaling in high glucose","volume":"50","author":"Jeong","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"key20200713224432_b11-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jpi.12296","article-title":"Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase","volume":"60","author":"Winiarska","year":"2016","journal-title":"J Pineal Res"},{"key":"key20200713224432_b12-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13105-016-0482-8","article-title":"Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats","volume":"72","author":"Jangale","year":"2016","journal-title":"J Physiol Biochem"},{"key":"key20200713224432_b13-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1681\/ASN.2013070811","article-title":"Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney","volume":"25","author":"Borsting","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key20200713224432_b14-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"e0134392","DOI":"10.1371\/journal.pone.0134392","article-title":"FT011, a novel cardiorenal protective drug, reduces inflammation, gliosis and vascular injury in rats with diabetic retinopathy","volume":"10","author":"Deliyanti","year":"2015","journal-title":"PLoS One"},{"key":"key20200713224432_b15-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"948417","DOI":"10.1155\/2015\/948417","article-title":"Inflammatory cytokines in diabetic nephropathy","volume":"2015","author":"Donate-Correa","year":"2015","journal-title":"J Diabetes Res"},{"key":"key20200713224432_b16-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1007\/s11064-013-1153-6","article-title":"Oxysophoridine protects against focal cerebral ischemic injury by inhibiting oxidative stress and apoptosis in mice","volume":"38","author":"Wang","year":"2013","journal-title":"Neurochem Res"},{"key":"key20200713224432_b17-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713224432_b18-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fphar.2016.00328","article-title":"Placenta peptide can protect mitochondrial dysfunction through inhibiting ROS and TNF-\u03b1 generation, by maintaining mitochondrial dynamic network and by increasing il-6 level during chronic fatigue","volume":"7","author":"Muluye","year":"2016","journal-title":"Front Pharmacol"},{"key":"key20200713224432_b19-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1042\/CS20140111","article-title":"Effects of folic acid on renal endothelial function in patients with diabetic nephropathy: Results from a randomized trial","volume":"127","author":"Schneider","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"key20200713224432_b20-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"F1271","DOI":"10.1152\/ajprenal.00065.2010","article-title":"Attenuating effect of angiotensin-(1\u20137) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)\/Ta mice","volume":"300","author":"Moon","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200713224432_b21-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1159\/000356619","article-title":"AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-\u03baB pathway in rat mesangial cells: Inhibition by sesquiterpene lactones","volume":"32","author":"Wang","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"key20200713224432_b22-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/1470320311422581","article-title":"Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat","volume":"13","author":"Pess\u00f4a","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key20200713224432_b23-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/db07-1119","article-title":"Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway","volume":"57","author":"Thallas-Bonke","year":"2008","journal-title":"Diabetes"},{"key":"key20200713224432_b24-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mce.2014.12.010","article-title":"Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase\/ROS\/ERK pathway","volume":"402","author":"He","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"key20200713224432_b25-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI72326","article-title":"Mitochondrial ROS deficiency and diabetic complications: AMP [K]-lifying the adaptation to hyperglycemia","volume":"123","author":"Towler","year":"2013","journal-title":"J Clin Invest"},{"key":"key20200713224432_b26-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.biocel.2012.01.001","article-title":"High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK\/NF-\u03baB\/NADPH oxidase\/ROS pathway, which is inhibited by resveratrol","volume":"44","author":"Zhang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"key20200713224432_b27-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1681\/ASN.2013070810","article-title":"Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy","volume":"25","author":"Jha","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key20200713224432_b28-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jdiacomp.2015.02.011","article-title":"SMART2D study: Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes","volume":"29","author":"Liu","year":"2015","journal-title":"J Diabetes Complications"},{"key":"key20200713224432_b29-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mvr.2011.01.001","article-title":"Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells","volume":"81","author":"Matsui","year":"2011","journal-title":"Microvasc Res"},{"key":"key20200713224432_b30-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"e40427","DOI":"10.1371\/journal.pone.0040427","article-title":"Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy","volume":"7","author":"Alkhalaf","year":"2012","journal-title":"PLoS One"},{"key":"key20200713224432_b31-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1242\/dmm.019398","article-title":"Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy","volume":"8","author":"Jheng","year":"2015","journal-title":"Dis Model Mech"},{"key":"key20200713224432_b32-mmr-17-03-4759","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/1440-1681.12494","article-title":"Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy","volume":"43","author":"Yaghobian","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:55:21Z","timestamp":1594680921000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8407","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]}}}